Literature DB >> 26075933

Are pleural plaques an appropriate endpoint for risk analyses?

L Daniel Maxim1, Ronald Niebo, Mark J Utell.   

Abstract

This review summarizes the literature on the relation between the development of pleural plaques and non-malignant and malignant disease in cohorts exposed to asbestos and other fibers. The available evidence indicates that, absent any other pleural disease, the presence of pleural plaques does not result in respiratory symptoms or clinically significant impacts on lung function. For certain types of asbestos, the development of pleural plaques is statistically correlated with malignant disease, but the evidence is consistent with the hypothesis that pleural plaques without other pleural disease are a marker of exposure, rather than an independent risk factor. Pleural plaques have also developed in cohorts exposed to other fibers that have not proven to be carcinogenic. Risk analyses should be based on the avoidance of known adverse conditions, rather than pleural plaques per se.

Entities:  

Keywords:  Asbestos; lung cancer; lung function; mesothelioma; non-malignant respiratory disease; other natural and synthetic fibers; pleural plaques; respiratory symptoms; risk analysis

Mesh:

Substances:

Year:  2015        PMID: 26075933     DOI: 10.3109/08958378.2015.1051640

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  6 in total

1.  Incidental and Underreported Pleural Plaques at Chest CT: Do Not Miss Them-Asbestos Exposure Still Exists.

Authors:  Maria Antonietta Mazzei; Francesco Contorni; Francesco Gentili; Susanna Guerrini; Francesco Giuseppe Mazzei; Antonio Pinto; Nevada Cioffi Squitieri; Antonietta Gerardina Sisinni; Valentina Paolucci; Riccardo Romeo; Pietro Sartorelli; Luca Volterrani
Journal:  Biomed Res Int       Date:  2017-06-05       Impact factor: 3.411

2.  Potential asbestos exposure among patients with primary lung cancer in Japan.

Authors:  Akihiko Tamura; Mitsuhiko Funakoshi; Naw Awn J-P; Kichinori Hasegawa; Atsushi Ishimine; Akio Koike; Noriyuki Tannai; Masami Fujii; Makoto Hattori; Harukazu Hirano; Kenji Nakamura; Masanobu Funakoshi; Kazuhiko Satomi; Yoshihito Yamashita; Yasuma Fukuchi; Narufumi Suganuma
Journal:  J Occup Health       Date:  2018-03-20       Impact factor: 2.708

3.  The role of polymorphisms in glutathione-related genes in asbestos-related diseases.

Authors:  Alenka Franko; Katja Goricar; Metoda Dodic Fikfak; Viljem Kovac; Vita Dolzan
Journal:  Radiol Oncol       Date:  2021-01-26       Impact factor: 2.991

4.  Deep Learning for the Automatic Quantification of Pleural Plaques in Asbestos-Exposed Subjects.

Authors:  Ilyes Benlala; Baudouin Denis De Senneville; Gael Dournes; Morgane Menant; Celine Gramond; Isabelle Thaon; Bénédicte Clin; Patrick Brochard; Antoine Gislard; Pascal Andujar; Soizick Chammings; Justine Gallet; Aude Lacourt; Fleur Delva; Christophe Paris; Gilbert Ferretti; Jean-Claude Pairon; François Laurent
Journal:  Int J Environ Res Public Health       Date:  2022-01-27       Impact factor: 3.390

5.  Analysis of Mortality from Asbestos-Related Diseases in Brazil Using Multiple Health Information Systems, 1996-2017.

Authors:  Eduardo Algranti; Vilma S Santana; Felipe Campos; Leonardo Salvi; Cézar A Saito; Franciana Cavalcante; Heleno R Correa-Filho
Journal:  Saf Health Work       Date:  2022-05-06

6.  NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases.

Authors:  Alenka Franko; Katja Goricar; Viljem Kovac; Metoda Dodic-Fikfak; Vita Dolzan
Journal:  J Med Biochem       Date:  2020-01-10       Impact factor: 3.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.